1-12273 | 51-0263969 |
(COMMISSION FILE NUMBER) | (IRS EMPLOYER IDENTIFICATION NO.) |
6901 PROFESSIONAL PKWY. EAST, SUITE 200, SARASOTA, FLORIDA | 34240 |
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) | (ZIP CODE) |
Roper Technologies, Inc. | |||||||
(Registrant) | |||||||
BY: | /S/ Robert C. Crisci | Date: | April 25, 2019 | ||||
Robert C. Crisci, Executive Vice President and Chief Financial Officer |
Contact Information: Investor Relations 941-556-2601 investor-relations@ropertech.com | Roper Technologies, Inc. |
Table 1: Adjusted Revenue Reconciliation and Growth Detail ($M) | ||||||||||
Q1 2018 | Q1 2019 | V % | ||||||||
GAAP Revenue | $ | 1,203 | $ | 1,287 | 7 | % | ||||
Purchase accounting adjustment to acquired deferred revenue | 2 | 1 | A | |||||||
Adjusted Revenue | $ | 1,205 | $ | 1,288 | 7 | % | ||||
Components of Adjusted Revenue Growth | ||||||||||
Organic | 6 | % | ||||||||
Acquisitions/Divestitures | 2 | % | ||||||||
Foreign Exchange | (1 | )% | ||||||||
Total Adjusted Revenue Growth | 7 | % | ||||||||
Table 2: Adjusted Gross Margin Reconciliation ($M) | ||||||||||
Q1 2018 | Q1 2019 | V% / Bps | ||||||||
GAAP Revenue | $ | 1,203 | $ | 1,287 | 7 | % | ||||
Purchase accounting adjustment to acquired deferred revenue | 2 | 1 | A | |||||||
Adjusted Revenue | $ | 1,205 | $ | 1,288 | 7 | % | ||||
GAAP Gross Profit | $ | 750 | $ | 811 | ||||||
Purchase accounting adjustment to acquired deferred revenue | 2 | 1 | A | |||||||
Adjusted Gross Profit | $ | 753 | $ | 811 | 8 | % | ||||
GAAP Gross Margin | 62.4 | % | 63.0 | % | +60 bps | |||||
Adjusted Gross Margin | 62.5 | % | 63.0 | % | +50 bps | |||||
Table 3: Adjusted EBITDA Reconciliation ($M) | ||||||||||
Q1 2018 | Q1 2019 | V% / Bps | ||||||||
GAAP Revenue | $ | 1,203 | $ | 1,287 | 7 | % | ||||
Purchase accounting adjustment to acquired deferred revenue | 2 | 1 | A | |||||||
Adjusted Revenue | $ | 1,205 | $ | 1,288 | 7 | % | ||||
GAAP Net Earnings | 211 | 370 | ||||||||
Taxes | 44 | 50 | ||||||||
Interest Expense | 43 | 44 | ||||||||
Depreciation | 13 | 12 | ||||||||
Amortization | 75 | 83 | ||||||||
EBITDA | $ | 386 | $ | 558 | 44 | % | ||||
Purchase accounting adjustment to acquired deferred revenue and commission expense | 2 | — | ||||||||
Gain on sale of Scientific Imaging businesses B | — | (120 | ) | |||||||
Adjusted EBITDA | $ | 389 | $ | 438 | 13 | % | ||||
% of Adjusted Revenue | 32.3 | % | 34.0 | % | +170 bps | |||||
Table 4: Adjusted Earnings Before Taxes Reconciliation ($M) | ||||||||||
Q1 2018 | Q1 2019 | V % | ||||||||
GAAP Earnings Before Taxes | $ | 255 | $ | 419 | 64 | % | ||||
Purchase accounting adjustment to acquired deferred revenue and commission expense | 2 | — | ||||||||
Amortization of acquisition-related intangible assets C | 74 | 82 | ||||||||
Gain on sale of Scientific Imaging businesses B | — | (120 | ) | |||||||
Adjusted Earnings Before Taxes | $ | 332 | $ | 382 | 15 | % |
Table 5: Adjusted DEPS Reconciliation D | ||||||||||
Q1 2018 | Q1 2019 | V % | ||||||||
GAAP DEPS | $ | 2.03 | $ | 3.53 | 74 | % | ||||
Purchase accounting adjustment to acquired deferred revenue and commission expense | 0.02 | — | ||||||||
Amortization of acquisition-related intangible assets C | 0.56 | 0.62 | ||||||||
Gain on sale of Scientific Imaging businesses B | — | (0.86 | ) | |||||||
Rounding | — | 0.01 | ||||||||
Adjusted DEPS | $ | 2.61 | $ | 3.30 | 26 | % |
Table 6: Cash Flow Reconciliation ($M) | ||||||||||
Q1 2018 | Q1 2019 | V % | ||||||||
GAAP Operating Cash Flow | $ | 282 | $ | 290 | 3 | % | ||||
Add: Cash taxes paid on sale of Scientific Imaging businesses | — | 39 | ||||||||
Adjusted Operating Cash Flow | 282 | 330 | 17 | % | ||||||
Capital Expenditures | (10 | ) | (16 | ) | ||||||
Capitalized Software Expenditures | (2 | ) | (2 | ) | ||||||
Adjusted Free Cash Flow | $ | 270 | $ | 312 | 15 | % |
Table 7: Forecasted Adjusted DEPS Reconciliation D | |||||||||||||||
Q2 2019 | Full Year 2019 | ||||||||||||||
Low End | High End | Low End | High End | ||||||||||||
GAAP DEPS | $ | 2.38 | $ | 2.42 | $ | 11.08 | $ | 11.38 | |||||||
Amortization of acquisition-related intangible assets C | 0.62 | 0.62 | 2.48 | 2.48 | |||||||||||
Gain on sale of Scientific Imaging businesses B | — | — | (0.86 | ) | (0.86 | ) | |||||||||
Adjusted DEPS | $ | 3.00 | $ | 3.04 | $ | 12.70 | $ | 13.00 |
B. | Gain on sale of Scientific Imaging businesses ($120M pretax, $90M after-tax). |
C. | Actual results and forecast of estimated amortization of acquisition-related intangible assets ($M, except per share data); for comparison purposes, prior period amounts are also shown below. Tax rate of 21% applied to amortization. |
Q1'18A | Q1'19A | Q2'19E | FY'19E | ||||||||||||
Pretax | $ | 74 | $ | 82 | $ | 83 | $ | 330 | |||||||
After-tax | $ | 59 | $ | 65 | $ | 65 | $ | 261 | |||||||
Per share | $ | 0.56 | $ | 0.62 | $ | 0.62 | $ | 2.48 |
D. | All 2018 and 2019 adjustments taxed at 21%, except for the gain on sale of the Scientific Imagining businesses which was taxed at 25%. |
Roper Technologies, Inc. and Subsidiaries | |||||||
Condensed Consolidated Balance Sheets (unaudited) | |||||||
(Amounts in millions) | |||||||
March 31, 2019 | December 31, 2018 | ||||||
ASSETS: | |||||||
Cash and cash equivalents | $ | 392.5 | $ | 364.4 | |||
Accounts receivable, net | 629.3 | 700.8 | |||||
Inventories, net | 207.5 | 190.8 | |||||
Income taxes receivable | 18.5 | 21.7 | |||||
Unbilled receivables | 194.4 | 169.4 | |||||
Other current assets | 91.5 | 80.0 | |||||
Current assets held for sale | 52.3 | 83.6 | |||||
Total current assets | 1,586.0 | 1,610.7 | |||||
Property, plant and equipment, net | 132.2 | 128.7 | |||||
Right-of-use assets | 260.4 | — | |||||
Goodwill | 9,365.4 | 9,346.8 | |||||
Other intangible assets, net | 3,766.8 | 3,842.1 | |||||
Deferred taxes | 93.0 | 52.2 | |||||
Other assets | 104.8 | 101.1 | |||||
Assets held for sale | 95.3 | 167.9 | |||||
Total assets | $ | 15,403.9 | $ | 15,249.5 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY: | |||||||
Accounts payable | $ | 172.6 | $ | 165.3 | |||
Accrued compensation | 164.3 | 248.3 | |||||
Deferred revenue | 691.1 | 677.9 | |||||
Current operating lease liabilities | 52.7 | — | |||||
Other accrued liabilities | 245.3 | 258.0 | |||||
Income taxes payable | 78.7 | 58.3 | |||||
Current portion of long-term debt, net | 1.7 | 1.5 | |||||
Current liabilities held for sale | 24.2 | 38.9 | |||||
Total current liabilities | 1,444.7 | 1,448.2 | |||||
Long-term debt, net of current portion | 4,487.0 | 4,940.2 | |||||
Deferred taxes | 920.5 | 931.1 | |||||
Operating lease liabilities | 216.3 | — | |||||
Other liabilities | 190.1 | 191.5 | |||||
Liabilities held for sale | 7.9 | — | |||||
Total liabilities | 7,266.5 | 7,511.0 | |||||
Common stock | 1.1 | 1.1 | |||||
Additional paid-in capital | 1,799.9 | 1,751.5 | |||||
Retained earnings | 6,569.4 | 6,247.7 | |||||
Accumulated other comprehensive loss | (214.6 | ) | (243.3 | ) | |||
Treasury stock | (18.4 | ) | (18.5 | ) | |||
Total stockholders' equity | 8,137.4 | 7,738.5 | |||||
Total liabilities and stockholders' equity | $ | 15,403.9 | $ | 15,249.5 |
Roper Technologies, Inc. and Subsidiaries | ||||||||
Condensed Consolidated Statements of Earnings (unaudited) | ||||||||
(Amounts in millions, except per share data) | ||||||||
Three months ended March 31, | ||||||||
2019 | 2018 | |||||||
Net revenues | $ | 1,287.2 | $ | 1,202.5 | ||||
Cost of sales | 476.6 | 452.0 | ||||||
Gross profit | 810.6 | 750.5 | ||||||
Selling, general and administrative expenses | 464.2 | 450.3 | ||||||
Income from operations | 346.4 | 300.2 | ||||||
Interest expense, net | 43.7 | 43.2 | ||||||
Other income/(expense), net | (3.1 | ) | (1.7 | ) | ||||
Gain on disposal of business | 119.6 | — | ||||||
Earnings before income taxes | 419.2 | 255.3 | ||||||
Income taxes | 49.6 | 44.0 | ||||||
Net earnings | $ | 369.6 | $ | 211.3 | ||||
Net earnings per share: | ||||||||
Basic | $ | 3.57 | $ | 2.05 | ||||
Diluted | $ | 3.53 | $ | 2.03 | ||||
Weighted average common shares outstanding: | ||||||||
Basic | 103.6 | 102.9 | ||||||
Diluted | 104.7 | 104.2 |
Roper Technologies, Inc. and Subsidiaries | |||||||||||||
Selected Segment Financial Data (unaudited) | |||||||||||||
(Amounts in millions and percents of net revenues) | |||||||||||||
Three Months Ended March 31, | |||||||||||||
2019 | 2018 | ||||||||||||
Amount | % | Amount | % | ||||||||||
Net revenues: | |||||||||||||
Application Software | $ | 381.2 | $ | 323.9 | |||||||||
Network Software & Systems | 345.7 | 313.9 | |||||||||||
Measurement & Analytical Solutions | 401.8 | 404.0 | |||||||||||
Process Technologies | 158.5 | 160.7 | |||||||||||
Total | $ | 1,287.2 | $ | 1,202.5 | |||||||||
Gross profit: | |||||||||||||
Application Software | $ | 253.4 | 66.5 | % | $ | 213.9 | 66.0 | % | |||||
Network Software & Systems | 239.0 | 69.1 | % | 212.7 | 67.8 | % | |||||||
Measurement & Analytical Solutions | 231.2 | 57.5 | % | 234.0 | 57.9 | % | |||||||
Process Technologies | 87.0 | 54.9 | % | 89.9 | 55.9 | % | |||||||
Total | $ | 810.6 | 63.0 | % | $ | 750.5 | 62.4 | % | |||||
Operating profit*: | |||||||||||||
Application Software | $ | 91.4 | 24.0 | % | $ | 70.2 | 21.7 | % | |||||
Network Software & Systems | 125.3 | 36.2 | % | 106.0 | 33.8 | % | |||||||
Measurement & Analytical Solutions | 118.1 | 29.4 | % | 115.4 | 28.6 | % | |||||||
Process Technologies | 50.1 | 31.6 | % | 50.3 | 31.3 | % | |||||||
Total | $ | 384.9 | 29.9 | % | $ | 341.9 | 28.4 | % | |||||
*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $38.5 and $41.7 for the three months ended March 31, 2019 and 2018, respectively. |
Roper Technologies, Inc. and Subsidiaries | ||||||||
Condensed Consolidated Statements of Cash Flows (unaudited) | ||||||||
(Amounts in millions) | ||||||||
Three months ended March 31, | ||||||||
2019 | 2018 | |||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ | 369.6 | $ | 211.3 | ||||
Adjustments to reconcile net earnings to cash flows from operating activities: | ||||||||
Depreciation and amortization of property, plant and equipment | 11.7 | 12.6 | ||||||
Amortization of intangible assets | 82.9 | 75.3 | ||||||
Amortization of deferred financing costs | 1.7 | 1.6 | ||||||
Non-cash stock compensation | 25.3 | 26.0 | ||||||
Gain on disposal of businesses, net of associated income tax | (89.6 | ) | — | |||||
Changes in operating assets and liabilities, net of acquired businesses: | ||||||||
Accounts receivable | 88.9 | 17.3 | ||||||
Unbilled receivables | (25.3 | ) | (10.5 | ) | ||||
Inventories | (19.5 | ) | (9.0 | ) | ||||
Accounts payable and accrued liabilities | (92.8 | ) | (45.9 | ) | ||||
Deferred revenue | 11.9 | 26.3 | ||||||
Income taxes, excluding tax associated with gain on disposal of businesses | (17.6 | ) | (13.8 | ) | ||||
Cash tax paid for gain on disposal of businesses | (39.4 | ) | — | |||||
Other, net | (17.5 | ) | (9.5 | ) | ||||
Cash provided by operating activities | 290.3 | 281.7 | ||||||
Cash flows from (used in) investing activities: | ||||||||
Acquisitions of businesses, net of cash acquired | (3.2 | ) | (38.9 | ) | ||||
Capital expenditures | (15.8 | ) | (9.7 | ) | ||||
Capitalized software expenditures | (2.0 | ) | (1.9 | ) | ||||
Proceeds from disposal of business | 220.4 | — | ||||||
Proceeds from sale of assets | — | — | ||||||
Other, net | (2.2 | ) | (1.0 | ) | ||||
Cash from (used in) investing activities | 197.2 | (51.5 | ) | |||||
Cash flows used in financing activities: | ||||||||
Payments under revolving line of credit, net | (455.0 | ) | (535.0 | ) | ||||
Cash dividends to stockholders | (47.7 | ) | (42.1 | ) | ||||
Proceeds from stock-based compensation, net | 22.0 | 23.8 | ||||||
Treasury stock sales | 2.2 | 1.6 | ||||||
Other | 14.2 | 0.1 | ||||||
Cash used in financing activities | (464.3 | ) | (551.6 | ) | ||||
Effect of foreign currency exchange rate changes on cash | 4.9 | 16.3 | ||||||
Net increase (decrease) in cash and cash equivalents | 28.1 | (305.1 | ) | |||||
Cash and cash equivalents, beginning of period | 364.4 | 671.3 | ||||||
Cash and cash equivalents, end of period | $ | 392.5 | $ | 366.2 |